Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a dangerous complication of bisphosphonates, a class of pharmaceutical agents used in numerous bone disor-ders. No gold standard therapy exists, but recent literature suggests that, in advanced stages, the best results are achieved with aggressive debridement. In this paper, we report our experience of treatment of stage 3 BRONJ of the maxilla with extensive surgical debridement and reconstruction with a chimeric ALT-Vastus lateralis flap.
Five selected patients with stage 3 BRONJ underwent partial maxillectomy with dis-ease-free margins followed by immediate reconstruction with a chimeric ALT-Vastus lateralis free flap.
Only two patients experienced minor complications. All other patients healed unevent-fully within two weeks and donor site morbidity was minimal.
Our data suggest that aggressive debridement and reconstruction with a chimeric ALT-Vastus lateralis flap is an effective option for the treatment of stage III BRONJ of the maxilla.